INVASIVE EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI DISEASE (IED) PREVENTION
Clinical trials for INVASIVE EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI DISEASE (IED) PREVENTION explained in plain language.
Never miss a new study
Get alerted when new INVASIVE EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI DISEASE (IED) PREVENTION trials appear
Sign up with your email to follow new studies for INVASIVE EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI DISEASE (IED) PREVENTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to stop dangerous e. coli infections in seniors
Prevention CompletedThis large Phase 3 trial tested a vaccine called ExPEC9V in nearly 18,000 adults aged 60 and older who had a urinary tract infection in the past two years. The goal was to see if the vaccine could prevent invasive E. coli disease, a serious infection that can spread to the blood …
Matched conditions: INVASIVE EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI DISEASE (IED) PREVENTION
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Prevention
Last updated Jun 27, 2026 13:02 UTC
-
One shot, two protections? new study combines e. coli and flu vaccines for seniors
Prevention CompletedThis study tested whether a new vaccine against certain E. coli bacteria (ExPEC9V) can be given at the same time as a high-dose flu shot in adults aged 65 and older. The goal was to see if the immune response to both vaccines remains strong when given together. About 959 particip…
Matched conditions: INVASIVE EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI DISEASE (IED) PREVENTION
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC